Send us Fan Mail Welcome to Episode 30 of The Oncology Podcast's Experts On Point series, brought to you by The Oncology Network. Hosted by Rachael Babin. What does it really take to make cancer care smarter? In this episode of Experts on Point, host Rachael Babin is joined by Associate Professor Jenny Liu and patient advocate Beth Ivimey to explore how precision oncology is reshaping not only cancer treatment but the way clinical trials are designed and delivered. It's a conversat...
Jul 6
44 min
Send us Fan Mail Join our Hosts Professor Craig Underhill and Rachael Babin to discuss the June 2026 PBS update including a new listing for fixed-duration acalabrutinib plus venetoclax in chronic lymphocytic leukaemia. They also explore the growing challenges facing Australia's PBS, with special guest Professor John Zalcberg AO sharing his insights into delays in access to innovative cancer medicines, global pricing pressures, the impact of changing US drug policy and what reforms may b...
Jun 30
32 min
Send us Fan Mail S4E5 The Oncology Journal Club Podcast The Oncology Journal Club team returns with Part 2 of its ASCO 2026 coverage, delivering a whirlwind tour through some of the most interesting studies presented across gastrointestinal, breast, lung, genitourinary, gynaecological, skin and haematological cancers. Craig Underhill, Kate Clarke and Christopher Jackson discuss emerging data on ctDNA-guided treatment strategies, exercise as adjuvant therapy, genomic testing in breast ca...
Jun 13
49 min
Send us Fan Mail S4E4 The Oncology Journal Club Podcast In this special ASCO 2026 edition of The Oncology Journal Club, Craig Underhill, Chris Jackson and Kate Clarke unpack some of the meeting’s most talked-about studies and discuss what they could mean for clinical practice. From the PROTEUS trial in high-risk prostate cancer and promising advances in RET fusion-positive lung cancer, to a rare sarcoma study demonstrating the potential of CDK4 inhibition, the team explores the data behi...
Jun 9
47 min
Send us Fan Mail In this episode of The Oncology Journal Club, the team cover one of the most talked-about pancreatic cancer papers of the year, unpacking the promising early results for daraxonrasib in previously treated RAS-mutated pancreatic cancer and the science behind new RAS(ON) therapeutics. The team also discuss a fascinating phase II study of single-cycle neoadjuvant pembrolizumab in MMR-deficient colon cancer, new recommendations from the Prostate Cancer Working Group 4 and w...
May 20
45 min
Send us Fan Mail Proudly Produced by The Oncology Network Professor Craig Underhill and Rachael Babin break down the key oncology changes from the May 2026 PBS update. This month we run through 3 fresh PBS listings that affect Australian oncology and haematology practice, from fruquintinib, a late-line colorectal cancer treatment, through to new haematology options. Follow The PBS Update for regular discussions of PBS listings and oncology policy changes affecting Australian healthcare...
May 8
17 min
Send us Fan Mail In this episode of The Oncology Journal Club, the team weigh promising trial signals against the level of evidence needed to change clinical practice. From perioperative cholangiocarcinoma to molecular matching and chrono-oncology, the focus stays on a key question: what meaningfully improves outcomes for patients? What’s covered NeoGOLP trial in high-risk resectable iCCA: improved event-free survival; overall survival still immature MoST programme: molecular...
Apr 23
38 min
Send us Fan Mail Proudly Produced by The Oncology Network Professor Craig Underhill and Rachael Babin break down the key oncology changes from the April 2026 PBS update. This month we run through six fresh PBS listings and policy changes that affect Australian oncology and haematology practice, from ROS1-positive non small cell lung cancer to perioperative immunotherapy and late-line blood cancer options. We focus on who benefits, what the key trial signals are and what clinicians need ...
Apr 15
20 min
Send us Fan Mail Australia’s PBS has introduced it’s first pan-tumour reimbursement listing for the immunotherapy combination nivolumab plus ipilimumab. In this inaugural episode of PBS Update, Professor Craig Underhill and Rachael Babin break down the key oncology changes from the March 2026 PBS update, including new listings for toripalimab and cabozantinib. Follow PBS Update for regular discussions on PBS listings and oncology policy changes affecting Australian healthcare professionals. V...
Mar 9
16 min
Send us Fan Mail The Oncology Journal Club Podcast hosted by Professor Craig Underhill, Dr Kate Clarke and Professor Chris Jackson | Proudly Produced by The Oncology Network Visit oncologynetwork.com.au for Show Notes, to send us Voice Notes and more information. We explore practical wins and bold ideas across supportive care, colorectal cancer prevention, immunotherapy timing, digital triage and equity. From halving hot flushes with an NK1/NK3 blocker to biomarker-guided aspirin in col...
Mar 5
43 min
Load more